New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
New hope for reduced long-term side effects in children after leukemia treatment

New hope for reduced long-term side effects in children after leukemia treatment

byUniversity of OsloResearcher Nina Richartz at the Department of Molecular Medicine at the University of Oslo. Credit: Cecilie Bakken Hostmark, UiOBy using drugs currently used to treat other d
Pediatrics December 26,2023
New hope for reduced long-term side effects in children after leukemia treatment

New hope for reduced long-term side effects in children after leukemia treatment

byUniversity of OsloResearcher Nina Richartz at the Department of Molecular Medicine at the University of Oslo. Credit: Cecilie Bakken Hostmark, UiOBy using drugs currently used to treat other d
Pediatrics December 26,2023
Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang
Oncology December 25,2023
Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang
Oncology December 25,2023
CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

by Impact Journals LLCSignaling of dimeric CEACAM1 long tail isoform in epithelial cells and T cells. Credit:Genes & Cancer(2023). DOI: 10.18632/genesandcancer.230A new review was rece
Oncology December 25,2023
CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

CEACAMS 1, 5, and 6 in disease and cancer: Interactions with pathogens

by Impact Journals LLCSignaling of dimeric CEACAM1 long tail isoform in epithelial cells and T cells. Credit:Genes & Cancer(2023). DOI: 10.18632/genesandcancer.230A new review was rece
Oncology December 25,2023
Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

by Nina Louis, Medizin & WissenschaftCredit:Blood(2022). DOI: 10.1182/blood-2022-159962Prior to allogeneic stem cell transplantation for the treatment of acute myeloid leukemia (AML),
Oncology December 25,2023
Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care

by Nina Louis, Medizin & WissenschaftCredit:Blood(2022). DOI: 10.1182/blood-2022-159962Prior to allogeneic stem cell transplantation for the treatment of acute myeloid leukemia (AML),
Oncology December 25,2023
Novel therapeutic target for acute myeloid leukemia

Novel therapeutic target for acute myeloid leukemia

by Melissa Rohman,Northwestern UniversityCredit: Unsplash/CC0 Public DomainNorthwestern Medicine investigators have discovered the mechanisms by which a particular protein promotes cancer cell p
Oncology December 25,2023
Novel therapeutic target for acute myeloid leukemia

Novel therapeutic target for acute myeloid leukemia

by Melissa Rohman,Northwestern UniversityCredit: Unsplash/CC0 Public DomainNorthwestern Medicine investigators have discovered the mechanisms by which a particular protein promotes cancer cell p
Oncology December 25,2023
Even moderate exercise linked to reduced mortality after breast cancer

Even moderate exercise linked to reduced mortality after breast cancer

by Elana GotkineEven moderate physical activity is associated with a reduced risk for mortality for breast cancer survivors, according to a study published online Nov. 17 inJAMA Network Open.Lie
Oncology December 25,2023
Even moderate exercise linked to reduced mortality after breast cancer

Even moderate exercise linked to reduced mortality after breast cancer

by Elana GotkineEven moderate physical activity is associated with a reduced risk for mortality for breast cancer survivors, according to a study published online Nov. 17 inJAMA Network Open.Lie
Oncology December 25,2023
Point-of-care biosensor rapidly detects oral cancer

Point-of-care biosensor rapidly detects oral cancer

byAmerican Institute of PhysicsPhoto of the group’s circuit board for the biosensor. Credit: Minghan Xian, Jenna L. Stephany, Chan-Wen Chiu, Chao-Cing Chiang, Fan Ren, Cheng-Tse Tsai, Siang-Sin
Oncology December 25,2023
Point-of-care biosensor rapidly detects oral cancer

Point-of-care biosensor rapidly detects oral cancer

byAmerican Institute of PhysicsPhoto of the group’s circuit board for the biosensor. Credit: Minghan Xian, Jenna L. Stephany, Chan-Wen Chiu, Chao-Cing Chiang, Fan Ren, Cheng-Tse Tsai, Siang-Sin
Oncology December 25,2023
Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

by Impact Journals LLCImpact of splicing variants. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28358In oncogenetics, some patients could be considered as "extreme phenotypes,&qu
Oncology December 25,2023
Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

by Impact Journals LLCImpact of splicing variants. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28358In oncogenetics, some patients could be considered as "extreme phenotypes,&qu
Oncology December 25,2023
Timely surveillance with chest imaging may benefit colorectal cancer patients

Timely surveillance with chest imaging may benefit colorectal cancer patients

byAmerican College of SurgeonsEarly chest imaging may benefit colorectal cancer patients. Credit: American College of SurgeonsColorectal cancer patients with certain clinical characteristics may
Oncology December 25,2023
Timely surveillance with chest imaging may benefit colorectal cancer patients

Timely surveillance with chest imaging may benefit colorectal cancer patients

byAmerican College of SurgeonsEarly chest imaging may benefit colorectal cancer patients. Credit: American College of SurgeonsColorectal cancer patients with certain clinical characteristics may
Oncology December 25,2023
Deep learning–based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

Deep learning–based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

byUCLA Engineering Institute for Technology AdvancementVirtual HER2 staining of unlabeled breast tissue sections using deep learning. Credit: Ozcan Lab @ UCLA.Breast cancer is one the leading ca
Oncology December 25,2023
Deep learning–based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

Deep learning–based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

byUCLA Engineering Institute for Technology AdvancementVirtual HER2 staining of unlabeled breast tissue sections using deep learning. Credit: Ozcan Lab @ UCLA.Breast cancer is one the leading ca
Oncology December 25,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com